• English
  • 简体中文
Login Register
Current Location: Home > Drug Registration and Acceptance subscription Help
-
-
-
Visualized Analysis Export Evaluation Conclusion Evaluation Progress
Acceptance No. Drug Name Active Ingredient Dosage Form Classification Submission Acceptance Date Manufacturers Manufacturers Review Status Status Date View
CYSB2000040 注射用重组人尿激酶原 recombinant human pro-urokinase Lyophilized Biological Products Supplementary Application 2020-03-12 天士力生物医药股份有限公司 Shanghai Tasly Pharmaceutical Co Ltd In Review 2020-03-11 view
CYSB1900006 注射用重组人尿激酶原 recombinant human pro-urokinase Lyophilized Biological Products Supplementary Application 2019-01-23 天士力生物医药股份有限公司 Shanghai Tasly Pharmaceutical Co Ltd Certificate Issued 2020-03-13 view
CXSS2100013 注射用重组人尿激酶原 recombinant human pro-urokinase Lyophilized Biological Products(2.2) New Drug Application 2021-02-03 天士力生物医药股份有限公司 Shanghai Tasly Pharmaceutical Co Ltd In Review 2021-02-02 view
CXSL2000019 重组全人源抗PCSK9单克隆抗体注射液 Injection Biological Products(1) New Drug Application 2020-02-14 天士力生物医药股份有限公司 Shanghai Tasly Pharmaceutical Co Ltd In Review 2020-02-13 view
CXSL1900082 培重组人成纤维细胞生长因子21注射液 Injection Biological Products(1) New Drug Application 2019-08-01 天士力生物医药股份有限公司 Shanghai Tasly Pharmaceutical Co Ltd In Review 2019-07-30 view